«Swiss Statement»: A two-year follow-up;«Swiss Statement»: Bilan deux ans après

Revue Medicale Suisse

Volumn 6, Issue 243, 2010, Pages 714-720

  Kuzoe Liengme, Bayi ^a   Hirschel, Bernard ^b   Schiffer, Véronique ^b  

^a Clinique Rousseau   (Switzerland)

^b Service des Maladies Infectieuses   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RITONAVIR; SAQUINAVIR; STAVUDINE; ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; CONDOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION; ADVISORY COMMITTEE; ARTICLE; DISEASE TRANSMISSION; FOLLOW UP; SWITZERLAND;

ADVISORY COMMITTEES; ANTI-RETROVIRAL AGENTS; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; SWITZERLAND;

EID: 77951289361     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immuno-deficiency virus type I. Rakai Project Study Group. N Engl J Med 2000;342:921-929
2. * Vernazza P, Hirschel B, Bemasconi E, et al. Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Med Suisses 2008:89:165-169
3. Castilla J, del Romero J, Hernando V, et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 2005;40:96-101. (Pubitemid 41233212)
4. Barreiro P, del Romero J, Leal M, et al. Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy. J Acquir Immune Defic Syndr 2006;43:324-326 (Pubitemid 44674013)
5. Garcia PM, Kalish LA, Pitt J. et al. Maternal levels of plasma human immunodeficiency virus type I RNA and the risk of perinatal transmission. N Engl J Med 1999;431:394-402. (Pubitemid 29362512)
6. Arendt V. AMATA study: Effectiveness of antiretroviral therapy in breastfeeding mothers to prevent post-natal vertical transmission in Rwanda. 4th IAS Conference, Sydney, July 2007; abstract TUAX 102.
7. Chakraborty H, Sen P, Pranab K, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-I: A probabilistic empiric model. AIDS 2001;15:621-627 (Pubitemid 32281358)
8. Vernazza PL, Troiani L, Flepp MJ, et al; the Swiss HIV cohort study. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HlV. AIDS 2000:14:117-121
9. Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-I RNA. AIDS 2000;14:415-421 (Pubitemid 30182438)
10. Vettere MV, Schechter M, Melo MF, Boechat LJ, Barroso PF. Genital HIV-I viral load is correlated with blood plasma HIV-I viral load in Brazilian women and is reduced by antiretroviral therapy. J Infect 2006:52:290-293
11. Stunner M, Doerr HW, Berger A, Gute P, et al. Is transmission of HIV-I in non-viraemic serodiscordant couples possible? Antiviral Therapy 2008;13:729-732
12. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004;18:81-88 (Pubitemid 38402321)
13. Marcelin AG, Tubiana R, Lambert-Niclot S, et al. Detection of HIV-I RNA in seminal plasma samples from treated patients with undetectable HIV-I RNA in blood plasma. AIDS 2008;22:1677-1678
14. Vernazza PL, Kashuba DM, Cohen MS. Biological correlates of sexual transmission of HIV: Practical consequences and potential targets for public health. Rev Med Microbiol 2001;12:131-142
15. Neely MN, Benning L, Xu J, et al. Cervical shedding of HIV-I RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007;44:38-42. (Pubitemid 46052218)
16. Kovacs A, Wasserman SS, Burns D, et al. Determinants of HIV-I shedding in the genital tract of women. Lancet 2001;358:1593-1601 (Pubitemid 33101909)
17. Nunnari G, Otero M, Dornadula G, et al. Residual HIV-I disease in seminal cells of HIV-I-infected men on suppressive HAART: Latency without on-going cellular infections. AIDS 2002:16:39-45. (Pubitemid 34062180)
18. * Attia S, Egger M, Muller M, et al. Sexual transmission of HIV-I according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS 2009;23:1397-1404
19. Wilson DP, Law M, Grulich A, et al. Relation between HIV viral load and infectiousness: A model-based analysis. Lancet 2008:372:314-320 (Pubitemid 352020440)
20. * Garnett GP, Gazzard B, et al. Risk of HIV transmission in discordant couples. Lancet 2008:372:270-271
21. Lima V, Johnston K, Hogg R, et al. Expanded access to highly active antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV epidemic JID 2008;198:59-67. (Pubitemid 351920290)
22. Deutsche Aids Hilfe. Thérapie contre le VIH et la prévention. Document de prise de position de l'aide allemande contre le sida. Avril 2009. www.aidshitfe.de/media/de/0904-DAH-Papier-HIV-Therapie-und- Praevention-Franzoesisch.pdf (dernière consultation le 20.10.2009).
23. Conseil national du sida. Avis suivi de recommandations sur l'intérêt du traitement comme outil novateur de la lutte contre l'épidémie d'infections à VIH. avril 2009. www.cns.sant.fr/spip.php?article294 (dernière consultation le 20.10.2009).